Fagron N.V. Stock price

Equities

FAGR

BE0003874915

Pharmaceuticals

Real-time Euronext Bruxelles 07:38:03 2024-03-28 am EDT 5-day change 1st Jan Change
17.45 EUR -0.46% Intraday chart for Fagron N.V. +1.69% +5.06%
Sales 2024 * 832M 898M Sales 2025 * 890M 961M Capitalization 1.28B 1.38B
Net income 2024 * 81M 87.42M Net income 2025 * 96M 104M EV / Sales 2024 * 1.83 x
Net Debt 2024 * 241M 260M Net Debt 2025 * 200M 216M EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
15.8 x
P/E ratio 2025 *
13.3 x
Employees 3,282
Yield 2024 *
1.55%
Yield 2025 *
1.69%
Free-Float 94.72%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.46%
1 week+1.69%
Current month-2.89%
1 month-3.22%
3 months+4.30%
6 months+8.86%
Current year+5.06%
More quotes
1 week
16.73
Extreme 16.73
17.57
1 month
16.73
Extreme 16.73
18.10
Current year
16.52
Extreme 16.52
18.38
1 year
14.64
Extreme 14.64
18.38
3 years
10.80
Extreme 10.8
20.08
5 years
10.80
Extreme 10.8
23.26
10 years
3.70
Extreme 3.698
44.98
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 17-11-26
Director of Finance/CFO 45 08-04-30
Chief Operating Officer 52 22-05-08
Members of the board TitleAgeSince
Chairman 56 16-07-31
Director/Board Member 64 18-12-31
Chief Executive Officer 46 17-11-26
More insiders
Date Price Change Volume
24-03-28 17.45 -0.46% 2 206
24-03-27 17.53 +0.98% 34,318
24-03-26 17.36 +1.88% 60,241
24-03-25 17.04 -0.06% 37,579
24-03-22 17.05 -0.64% 32,695

Real-time Euronext Bruxelles, March 28, 2024 at 07:38 am EDT

More quotes
Fagron N.V. specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The group ensures the sale of pharmaceutical formulas and raw materials, provides third-party pharmaceutical compounding services to pharmacists and hospitals, etc.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
17.53 EUR
Average target price
21.58 EUR
Spread / Average Target
+23.10%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Fagron N.V. - Euronext Bruxelles